查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606329

腦脊髓液管理設備市場：按產品、年齡層和最終用戶 - 全球預測 2025-2030

Cerebrospinal Fluid Management Devices Market by Product (CSF Drainage Systems, CSF Shunts), Age Group (Adult, Geriatric, Pediatric), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腦脊髓液管理設備市場價值為17.3億美元，預計到2024年將達到18.3億美元，複合年成長率為6.05%，到2030年將達到26.1億美元。

腦脊髓液（CSF）管理設備市場包括旨在管理與腦脊髓液流入和排放相關的疾病的設備，這對於各種醫療狀況至關重要，例如水腦症、顱內高壓和創傷性腦損傷。這些設備透過調節腦脊髓液的壓力和流量，對於維持中樞神經系統的健康非常重要，並且主要應用於神經病學和神經外科，以降低腦損傷的風險，改善患者的治療效果。最終用途通常是醫院、神經外科診所和專科醫療中心。由於神經系統疾病發生率的上升、世界人口的老化以及對先進治療方案認知的提高，對腦脊髓液管理設備的需求正在增加。關鍵的成長要素包括醫療技術的快速進步、醫療保健支出的增加以及旨在提高現有設備性能的研發力度的活性化。新的商機在於整合感測器整合分流系統和遠端醫療功能等智慧技術，以提高病患監測和設備效率。然而，市場限制包括設備的高成本、需要熟練的專業人員來操作它們以及與這些設備相關的外科手術可能導致的併發症。此外，嚴格的法律規範和報銷挑戰也構成了重大障礙。創新可以專注於開發具有成本效益的微創設備，並透過易於使用的功能來提高患者的依從性。整合個人化醫療方法和人工智慧驅動的預測分析來預防併發症具有巨大的潛力。由於市場是動態的、技術不斷創新、競爭激烈，企業需要強調策略聯盟與合作，以擴大市場範圍、增強技術力。為了實現永續的業務成長，結合持續的產品創新、患者教育計劃和積極的監管合規可以提高市場滲透率並提高品牌信譽。

主要市場統計
基準年[2023] 17.3億美元
預計年份 [2024] 18.3億美元
預測年份 [2030] 26.1億美元
複合年成長率（%） 6.05%

市場動態：快速發展的腦脊髓液管理設備市場的關鍵市場洞察

供需的動態交互作用正在改變腦脊髓液管理設備市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 老年人口增加和生活方式的快速變化
    • 全球神經系統疾病增加
    • 全球醫療保健支出增加
  • 市場限制因素
    • 與使用腦脊髓液分流器相關的高成本和感染風險
  • 市場機會
    • 開發精確檢測和調整腦脊髓液排放變化的感測器系統
    • 活性化新型創新分流器的研發力度
  • 市場挑戰
    • 與腦脊髓液分流失敗或故障相關的風險

波特五力：駕馭腦脊髓液管理設備市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解對腦脊髓液管理設備市場的外部影響

外部宏觀環境因素在塑造腦脊髓液管理設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解腦脊髓液管理設備市場的競爭狀況

腦脊髓液管理設備市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣腦脊髓液管理裝置市場供應商績效評估

FPNV 定位矩陣是評估腦脊髓液管理設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃腦脊髓液管理設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對腦脊髓液管理設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇和生活方式的快速變化
      • 全球神經系統疾病發生率增加
      • 世界各地的醫療費用增加
    • 抑制因素
      • 與使用腦脊髓液分流器相關的設備成本高且有感染風險
    • 機會
      • 開發感測器系統以準確檢測和控制腦脊髓液排放的變化
      • 加強新型創新分流器的研發活動
    • 任務
      • 與腦脊髓液分流失敗或故障相關的風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章腦脊髓液管理設備市場：依產品

  • 腦脊髓液引流系統
    • 腰椎引流系統
    • 腦室引流系統
  • 腦脊髓液分流術
    • 可調式腦脊髓液分流器
    • 固定式腦脊髓液分流術

第7章腦脊髓液管理設備市場：依年齡層

  • 成人用
  • 老年病
  • 小兒科

第8章腦脊髓液管理設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
  • 神經中樞

第9章北美及南美洲腦脊髓液管理設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區腦脊髓液管理設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲腦脊髓液管理設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • B. Braun Melsungen AG
  • BeckerSmith Medical, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biogen Inc.
  • bioMerieux, SA
  • CereVasc, Inc.
  • Delta Surgical Ltd.
  • Enzo Biochem Inc.
  • G. Surgiwear Ltd.
  • Integra LifeSciences Corporation
  • IRRAS AB
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • MOLLER Medical GmbH
  • Natus Medical Incorporated
  • Neuromedex GmbH
  • Penumbra, Inc.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Sinduri Biotec
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
  • Stryker Corporation
  • Terumo Corporation
  • Trivitron Healthcare
  • Wellong Instruments Co., Ltd.
Product Code: MRR-DD0700E81DAC

The Cerebrospinal Fluid Management Devices Market was valued at USD 1.73 billion in 2023, expected to reach USD 1.83 billion in 2024, and is projected to grow at a CAGR of 6.05%, to USD 2.61 billion by 2030.

The cerebrospinal fluid (CSF) management devices market encompasses a range of products designed to manage disorders related to the flow and drainage of cerebrospinal fluid, essential in various medical conditions including hydrocephalus, intracranial hypertension, and traumatic brain injuries. These devices are critical in maintaining CNS health by regulating CSF pressure and flow, with applications primarily in neurology and neurosurgery to mitigate risks of brain damage and enhance patient outcomes. End-use scopes often involve hospitals, neurosurgery clinics, and specialized medical centers. The necessity of CSF management devices is accentuated by the rising incidence of neurological disorders, an aging global population, and growing awareness of advanced treatment options. Key growth factors include the rapid advancements in medical technology, increasing healthcare expenditure, and escalated research and development efforts aimed at improving existing device performance. Emerging opportunities lie in embracing smart technologies, such as sensor-integrated shunt systems and telemedicine capabilities, to enhance patient monitoring and device efficiency. However, market limitations include high costs of devices, the need for skilled professionals for operation, and potential complications arising from surgical procedures related to these devices. Moreover, stringent regulatory frameworks and reimbursement challenges pose significant hurdles. Innovation could focus on developing cost-effective and minimally invasive devices, as well as enhancing patient compliance through ease-of-use features. There's substantial potential in personalized medicine approaches and integrating AI-enabled predictive analytics to preempt complications. The market is dynamic, characterized by constant technological innovations and intensive competition, necessitating companies to focus on strategic partnerships and collaborations to expand market reach and enhance technological capabilities. For sustained business growth, embracing continuous product innovation, patient education programs, and proactive regulatory compliance can facilitate deeper market penetration and improved brand credibility.

KEY MARKET STATISTICS
Base Year [2023] USD 1.73 billion
Estimated Year [2024] USD 1.83 billion
Forecast Year [2030] USD 2.61 billion
CAGR (%) 6.05%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cerebrospinal Fluid Management Devices Market

The Cerebrospinal Fluid Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population and rapidly changing lifestyle
    • Global increase in the incidence of neurological diseases
    • Rising healthcare expenditure across the world
  • Market Restraints
    • High cost of devices and risk of infection with the usage of CSF shunts
  • Market Opportunities
    • Development of sensor systems for accurate detection and regulation of changes in CSF drainage
    • Increasing research and development activities for new and innovative shunts
  • Market Challenges
    • Risks associated with the failure and malfunctioning of CSF shunts

Porter's Five Forces: A Strategic Tool for Navigating the Cerebrospinal Fluid Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cerebrospinal Fluid Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cerebrospinal Fluid Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cerebrospinal Fluid Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cerebrospinal Fluid Management Devices Market

A detailed market share analysis in the Cerebrospinal Fluid Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cerebrospinal Fluid Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cerebrospinal Fluid Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cerebrospinal Fluid Management Devices Market

A strategic analysis of the Cerebrospinal Fluid Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cerebrospinal Fluid Management Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, BeckerSmith Medical, Inc., Bio-Rad Laboratories, Inc., Biogen Inc., bioMerieux, SA, CereVasc, Inc., Delta Surgical Ltd., Enzo Biochem Inc., G. Surgiwear Ltd., Integra LifeSciences Corporation, IRRAS AB, Johnson & Johnson Services, Inc., Medtronic PLC, MOLLER Medical GmbH, Natus Medical Incorporated, Neuromedex GmbH, Penumbra, Inc., Shenzhen New Industries Biomedical Engineering Co., Ltd., Sinduri Biotec, Sophysa SA, Spiegelberg GmbH & Co. KG, Stryker Corporation, Terumo Corporation, Trivitron Healthcare, and Wellong Instruments Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cerebrospinal Fluid Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across CSF Drainage Systems and CSF Shunts. The CSF Drainage Systems is further studied across Lumbar Drainage System and Ventricular Drainage System. The CSF Shunts is further studied across Adjustable CSF Shunts and Fixed CSF Shunts.
  • Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, Hospitals, and Neurological Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population and rapidly changing lifestyle
      • 5.1.1.2. Global increase in the incidence of neurological diseases
      • 5.1.1.3. Rising healthcare expenditure across the world
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of devices and risk of infection with the usage of CSF shunts
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of sensor systems for accurate detection and regulation of changes in CSF drainage
      • 5.1.3.2. Increasing research and development activities for new and innovative shunts
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with the failure and malfunctioning of CSF shunts
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cerebrospinal Fluid Management Devices Market, by Product

  • 6.1. Introduction
  • 6.2. CSF Drainage Systems
    • 6.2.1. Lumbar Drainage System
    • 6.2.2. Ventricular Drainage System
  • 6.3. CSF Shunts
    • 6.3.1. Adjustable CSF Shunts
    • 6.3.2. Fixed CSF Shunts

7. Cerebrospinal Fluid Management Devices Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Geriatric
  • 7.4. Pediatric

8. Cerebrospinal Fluid Management Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Hospitals
  • 8.5. Neurological Centers

9. Americas Cerebrospinal Fluid Management Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cerebrospinal Fluid Management Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cerebrospinal Fluid Management Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. BeckerSmith Medical, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biogen Inc.
  • 5. bioMerieux, SA
  • 6. CereVasc, Inc.
  • 7. Delta Surgical Ltd.
  • 8. Enzo Biochem Inc.
  • 9. G. Surgiwear Ltd.
  • 10. Integra LifeSciences Corporation
  • 11. IRRAS AB
  • 12. Johnson & Johnson Services, Inc.
  • 13. Medtronic PLC
  • 14. MOLLER Medical GmbH
  • 15. Natus Medical Incorporated
  • 16. Neuromedex GmbH
  • 17. Penumbra, Inc.
  • 18. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • 19. Sinduri Biotec
  • 20. Sophysa SA
  • 21. Spiegelberg GmbH & Co. KG
  • 22. Stryker Corporation
  • 23. Terumo Corporation
  • 24. Trivitron Healthcare
  • 25. Wellong Instruments Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY LUMBAR DRAINAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY VENTRICULAR DRAINAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY ADJUSTABLE CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY FIXED CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY NEUROLOGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023